Age. mean | 56.3±13.11 | 55.6±15.69 | 0.55 |
Sex (W/M) | 13/2 | 3/2 |
0.03
|
Smokers or ex smokers, n (%) | 10 (66.7) | 1 (20) | 0.06 |
CCP Antibody, positive n (%) | 8 (53.3) | 2 (40) | 0.60 |
Titer, median [IQR] | 430.5 [165.8–1874.2] | 47 [35–59] | 0.23 |
RF Positive, n (%) | 8 (53.3) | 2 (66) | 0.6 |
RF titer. median [IQR] | 213 [67.5–334.75] | 135 [74–196] | 0.6 |
ESR mean/ CRP mean | 32.1±21.4/ 4.7±7.8 | 24.6±21.8/ 0.80±0.83 | 0.84/0.21 |
DAS28, mean | 5.04±1.03 | 4.48±0.85 | 0.49 |
Bone erosions X ray, n (%) | 1 (6.7) | 1 (20) | 0.60 |
Carotid plaque, n (%) | 8 (53.3) | 2 (40) | 0.60 |
Extra articular manifestation, n (%) | 3 (20) | 0 | 0.16 |
– Sjögren Syndrome | 2 | | |
Abnormalities in thorax Rx. n (%) | 3 (20) | 0 | 0.16 |
Dyspnea, n (%) | 1 (6.7) | 0 | 0.60 |
DMARDs, n (%) | 8 | 4 | 0.60 |
Methotrexate,n (%) | 5 (55) | 2 (50) | |
Hydroxichloroquine, n (%) | 2 (33) | 2 (50) | |
Sulfasalazine, n (%) | 1 (12) | 0 | |